Extendicare Inc Forecast, price target & analysts
Extendicare Inc Target price 2026 - Analyst rating & recommendation
Extendicare Inc Classifications & Recommendation
Extendicare Inc Price Target
| Target Price | C$39.78 |
| Price | C$28.29 |
| Potential |
40.62%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Extendicare Inc 2027 .
The average Extendicare Inc target price is C$39.78.
This is
40.62%
register free of charge
C$47.25
67.02%
register free of charge
C$22.98
18.78%
register free of charge
|
|
| A rating was issued by 13 analysts: 12 Analysts recommend Extendicare Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Extendicare Inc stock has an average upside potential 2027 of
40.62%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion C$ | 1.66 | 2.33 |
| 13.25% | 40.27% | |
| EBITDA Margin | 10.58% | 10.97% |
| 7.28% | 3.72% | |
| Net Margin | 5.82% | 5.64% |
| 13.49% | 3.12% |
6 Analysts have issued a sales forecast Extendicare Inc 2026 . The average Extendicare Inc sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an Extendicare Inc EBITDA forecast 2026. The average Extendicare Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Extendicare Inc Analysts have issued a net profit forecast 2026. The average Extendicare Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share C$ | 1.11 | 1.38 |
| 42.31% | 24.32% | |
| P/E | 20.48 | |
| EV/Sales | 1.46 |
7 Analysts have issued a Extendicare Inc forecast for earnings per share. The average Extendicare Inc EPS is
This results in the following potential growth metrics and future valuations:
Extendicare Inc...
Current Extendicare Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| NATIONAL BANK FINANCIAL |
Locked
➜
Locked
|
Locked | Sep 21 2026 |
| ATB CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| CANACCORD GENUITY |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Aug 09 2026 |
| DESJARDINS SECURITIES |
Locked
➜
Locked
|
Locked | Aug 09 2026 |
| CIBC CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Aug 09 2026 |
| CIBC CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Jun 19 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
NATIONAL BANK FINANCIAL:
Locked
➜
Locked
|
Sep 21 2026 |
|
Locked
ATB CAPITAL MARKETS:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
CANACCORD GENUITY:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Aug 09 2026 |
|
Locked
DESJARDINS SECURITIES:
Locked
➜
Locked
|
Aug 09 2026 |
|
Locked
CIBC CAPITAL MARKETS:
Locked
➜
Locked
|
Aug 09 2026 |
|
Locked
CIBC CAPITAL MARKETS:
Locked
➜
Locked
|
Jun 19 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
